Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
ntravesical BCG is the gold-standard therapy for non-muscle invasive bladder cancer (NMIBC)
ntravesical BCG is the gold-standard therapy for non-muscle invasive bladder cancer (NMIBC)
Lung cancer (LC) continues to be the leading cause of cancer-related deaths in both men and women worldwide.
The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses.
We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.
However, after an intensive research work, our research group has discovered that we can induce trained immunity against COVID-19. The work has been published in the Frontiers in Immunology journal, and it is a collaboration between the Hospital la Paz Institute for health research (IdiPAZ), the National Center for Cardiovascular Research (CNIC) and the National…
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus.
The Coronavirus Disease of 2019 (COVID-19) pandemic caused by SARS-CoV-2 led the Spanish government to impose a national lockdown in an attempt to control the spread of the infection.
Colorectal cancer (CRC) is the second most deadly and third most commonly diagnosed cancer worldwide.